Acute Pulmonary Embolism and Immunity in Animal Models
References
- Bagot CN, Arya R (2008) Virchow and his triad: a question of attribution. Br J Haematol 143:180–190. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2141.2008.07323.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2141.2008.07323.x</a></pub-id>.
- Battistini B (2003) Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharmacol 81:555–569. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1139/y03-017" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1139/y03-017</a></pub-id>
- Becattini C, Agnelli G, Prandoni P et al (2005) A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 26:77–83. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/eurheartj/ehi018" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/eurheartj/ehi018</a></pub-id>
- Bergami M, Cenko E, Yoon J et al (2022) Statins for primary prevention among elderly men and women. Cardiovasc Res 118:3000–3009. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab348" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab348</a></pub-id>
- Biere-Rafi S, Hutten BA, Squizzato A et al (2013) Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J 34:1800–1806. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/eurheartj/eht046" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/eurheartj/eht046</a></pub-id>
- Bova C, Marchiori A, Noto A et al (2006) Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost 96:132–136.
- Brauninge H, B. Stoffers B, Fitzek ADE et al (2022) Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart. Cardiovasc Res 118:542–555. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab322" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab322</a></pub-id>
- Colotta F, Sciacca FL, Sironi M et al (1994) Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 144:975–985.
- Conti P, Pang X, Boucher W et al (1997) Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells. Int Immunol 9:1563–1570. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/intimm/9.10.1563" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/intimm/9.10.1563</a></pub-id>
- Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1038/35025229" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/35025229</a></pub-id>
- Dias-Junior CA, Cau SB, Oliveira AM et al (2009) Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress. Thromb Res 124:349–355.
- Ding WY, Protty MB, Davies IG et al (2022) Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovasc Res 118:716–731. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab017" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab017</a></pub-id>
- Dittmeier M, Kraft P, Schuhmann MK et al (2016) Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism. Thromb Haemost 115:835–843. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1160/TH15-08-0631" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1160/TH15-08-0631</a></pub-id>
- Doggen CJ, Lemaitre RN, Smith NL et al (2004) HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost 2:700–701. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/j.1538-7836.2004.00696" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1538-7836.2004.00696</a></pub-id>.
- Dolci DT, Fuentes CB, Rolim D et al (2010) Time course of haemo-dynamic, respiratory and inflammatory disturbances induced by experimental acute pulmonary polystyrene microembolism. Eur J Anaesthesiol 27:67–76. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1097/EJA.0b013e32832bfd7e" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/EJA.0b013e32832bfd7e</a></pub-id>
- Downing LJ, Strieter RM, Kadell AM et al (1996) Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 42:M677–682. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1097/00002480-199609000-00073" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/00002480-199609000-00073</a></pub-id>
- Downing LJ, Wakefield TW, Strieter RM et al (1997) Anti-P-select in antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 25:816–827; discussion 828. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/s0741-5214(97)70211-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s0741-5214(97)70211-8</a></pub-id>.
- Eagleton MJ, Henke PK, Luke CE et al (2002) Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg 36:581–588. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1067/mva.2002.126556" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1067/mva.2002.126556</a></pub-id>
- Ellinghaus P, Perzborn E, Hauenschild P et al (2016) Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran. Thromb Res 142:44–51. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.thromres.2016.04.008" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.thromres.2016.04.008</a></pub-id>
- Feng Y, Zhang F, Niu L et al (2016) Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system. Blood Coagul Fibrinolysis 27:531–541. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1097/MBC.0000000000000567" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/MBC.0000000000000567</a></pub-id>
- Fernandez-Patron C, Radomski MW, Davidge ST (1999) Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85:906–911. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/01.res.85.10.90" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/01.res.85.10.90</a></pub-id>
- Fernandez-Patron C, Stewart KG, Zhang Y et al (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87:670–676. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/01.res.87.8.670" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/01.res.87.8.670</a></pub-id>
- Galeano-Valle F, Ordieres-Ortega L, Oblitas CM et al (2021) Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review. Int J Mol Sci 2:2627. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.3390/ijms22052627" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/ijms22052627</a></pub-id>
- Gibbs J, Ince L, Matthews L et al (2014) An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action. Nat Med 20:919–926. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1038/nm.3599" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nm.3599</a></pub-id>
- Girotra S, Murarka S, Migrino RQ (2012) Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis. Panminerva Med 54:71–81.
- Glynn RJ, Danielson E, Fonseca FA et al (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360:1851–1861. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1056/NEJMoa0900241" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1056/NEJMoa0900241</a></pub-id>
- Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1146/annurev-immunol-032713-120145" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1146/annurev-immunol-032713-120145</a></pub-id>
- Gromadzinski L, Paukszto L, Lepiarczyk E et al (2023) Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease. BMC Genomics 24:10. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1186/s12864-023-09110-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s12864-023-09110-0</a></pub-id>.
- Haddad F, Hunt SA, Rosenthal DN et al (2008) Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117:1436–1448. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/CIRCULATIONAHA.107.653576" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/CIRCULATIONAHA.107.653576</a></pub-id>
- Halici B, Sarinc Ulasli S, Gunay E et al (2014) Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results. Inflammation 37:1186–1190. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s10753-014-9844-y" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10753-014-9844-y</a></pub-id>
- Hara T, Fukuda D, Tanaka K et al (2015) Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis 242:639–646. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.atherosclerosis.2015.03.023" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.atherosclerosis.2015.03.023</a></pub-id>
- Harjola VP, Mebazaa A, Celutkiene J et al (2016) Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 18:226–241. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/ejhf.478" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/ejhf.478</a></pub-id>
- Hettwer J, Hinterdobler J, Miritsch B et al (2022) Interleukin-1beta suppression dampens inflammatory leucocyte production and uptake in atherosclerosis. Cardiovasc Res 118:2778–2791. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab337" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab337</a></pub-id>
- Huisman MV, Barco S, Cannegieter SC et al (2018) Pulmonary embolism. Nat Rev Dis Primers 4:18028. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1038/nrdp.2018.28" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nrdp.2018.28</a></pub-id>
- Humphries J, McGuinness CL, Smith A et al (1999) Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 30:894–899. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/s0741-5214(99)70014-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s0741-5214(99)70014-5</a></pub-id>
- Iba T, Aihara K, Yamada A et al (2014) Rivaroxaban attenuates leukocyte adhesion in the microvasculature and thrombus formation in an experimental mouse model of type 2 diabetes mellitus. Thromb Res 133:276–280. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.thromres.2013.11.013" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.thromres.2013.11.013</a></pub-id>.
- Iwadate K, Doi M, Tanno K et al (2003) Right ventricular damage due to pulmonary embolism: examination of the number of infiltrating macrophages. Forensic Sci Int 134:147–153. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/s0379-0738(03)00138-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s0379-0738(03)00138-5</a></pub-id>
- Jackson SP, Darbousset R, Schoenwaelder SM (2019) Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood 133:906–918. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1182/blood-2018-11-882993" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood-2018-11-882993</a></pub-id>
- Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231.
- Jones AE, Watts JA, Debelak JP et al (2003) Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. Am J Physiol Lung Cell Mol Physiol 284:L1072–1081. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1152/ajplung.00283.2002" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1152/ajplung.00283.2002</a></pub-id>
- Joseph C, Berghausen EM, Behringer A et al (2022a) Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension. Cardiovasc Res 118:3225–3238. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvac004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvac004</a></pub-id>
- Joseph P, Glynn R, Lonn E et al (2022b) Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials. Cardiovasc Res 118:897–903. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab078" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab078</a></pub-id>
- Kapten K, Orczyk K, Smolewska E (2023) Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic. Arch Immunol Ther Exp 71:7. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s00005-023-00673-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00005-023-00673-0</a></pub-id>
- Klok FA, Ageno W, Ay C et al (2022) Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. Eur Heart J 43:183–189. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/eurheartj/ehab816" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/eurheartj/ehab816</a></pub-id>
- Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/eurheartj/ehz405" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/eurheartj/ehz405</a></pub-id>
- Konstantopoulos K, Neelamegham S, Burns AR et al (1998) Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin. Circulation 98:873–882. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/01.cir.98.9.873" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/01.cir.98.9.873</a></pub-id>
- Krata N, Foroncewicz B, Zagozdzon R et al (2021) Peroxiredoxins as markers of oxidative stress in IgA nephropathy, membranous nephropathy and lupus nephritis. Arch Immunol Ther Exp 70:3. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s00005-021-00638-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00005-021-00638-1</a></pub-id>
- Kreit JW (2004) The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest 125:1539–1545. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1378/chest.125.4.1539" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1378/chest.125.4.1539</a></pub-id>
- Kunutsor SK, Seidu S, Khunti K (2017) Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol 4:e83–e93. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/S2352-3026(16)30184-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S2352-3026(16)30184-3</a></pub-id>
- Kurnicka K, Lichodziejewska B, Goliszek S et al (2016) Echocardiographic pattern of acute pulmonary embolism: Analysis of 511 consecutive patients. J Am Soc Echocardiogr 29:907–913. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.echo.2016" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.echo.2016</a></pub-id>
- Lacut K, Oger E, Abalain JH et al (2004) Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial. Atherosclerosis 174:173–180. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.atherosclerosis.2004.01.021" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.atherosclerosis.2004.01.021</a></pub-id>
- Laurent M, Joimel U, Varin R et al (2014) Comparative study of the effect of rivaroxaban and fondaparinux on monocyte's coagulant activity and cytokine release. Exp Hematol Oncol 3:30. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1186/2162-3619-3-30" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/2162-3619-3-30</a></pub-id>
- Li CR, Wang LM, Gong Z et al (2015) Expression characteristics of neutrophil and mononuclear-phagocyte related genes mRNA in the stable angina pectoris and acute myocardial infarction stages of coronary artery disease. J Geriatr Cardiol 12:279–286. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.11909/j.issn.1671-5411.2015.03.021" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.11909/j.issn.1671-5411.2015.03.021</a></pub-id>
- Li Y, Hook JS, Ding Q et al (2023) Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extra-cellular trap formation. Nat Commun 14:2610. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1038/s41467-023-37567-w" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/s41467-023-37567-w</a></pub-id>
- Ma Y, Zhang Y, Qiu C et al (2021) Rivaroxaban suppresses atherosclerosis by inhibiting FXa-induced macrophage M1 polarization-mediated phenotypic conversion of vascular smooth muscle cells. Front Cardiovasc Med 8:739212. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.3389/fcvm.2021.739212" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3389/fcvm.2021.739212</a></pub-id>
- Martinez A, Oh HR, Unsworth EJ et al (2004) Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J 383(Pt 3):413–418. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1042/BJ20040920" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1042/BJ20040920</a></pub-id>
- McConnell MV, Solomon SD, Rayan ME et al (1996) Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 78:469–473. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/s0002-9149(96)00339-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s0002-9149(96)00339-6</a></pub-id>
- Mikolajczyk TP, Szczepaniak P, Vidler F et al (2021) Role of inflammatory chemokines in hypertension. Pharmacol Ther 223:107799. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.pharmthera.2020.107799" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.pharmthera.2020.107799</a></pub-id>
- Neto-Neves EM, Dias-Junior CA, Uzuelli JA et al (2011) Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. Eur J Pharmacol 670:554–560. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ejphar.2011.09.018" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejphar.2011.09.018</a></pub-id>
- Nishijima Y, Hader SN, Hanson AJ et al (2022) Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovasc Res 118:18–19. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab339" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab339</a></pub-id>
- Owens AP 3rd, Byrnes JR, Mackman N (2014) Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends Cardiovasc Med 24:95–98. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.tcm.2013.07.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.tcm.2013.07.003</a></pub-id>
- Patterson KA, Zhang X, Wrobleski SK et al (2013) Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. Thromb Res 131:268–276. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.thromres.2012.12.006" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.thromres.2012.12.006</a></pub-id>
- Potere N, Garrad E, Kanthi Y et al (2023) NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. Cardiovasc Res 119:2046–2060. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvad084" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvad084</a></pub-id>
- Pruszczyk P, Goliszek S, Lichodziejewska B et al (2014) Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging 7:553–560. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.jcmg.2013.11.004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jcmg.2013.11.004</a></pub-id>
- Ramcharan AS, Van Stralen KJ, Snoep JD et al (2009) HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. J Thromb Haemost 7:514–520. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/j.1538-7836.2008.03235.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1538-7836.2008.03235.x</a></pub-id>
- Ray JG, Mamdani M, Tsuyuki RT et al (2001) Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 161:1405–1410. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1001/archinte.161.11.1405" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1001/archinte.161.11.1405</a></pub-id>
- Ribeiro A, Lindmarker P, Juhlin-Dannfelt A et al (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134:479–487. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/s0002-8703(97)70085-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s0002-8703(97)70085-1</a></pub-id>
- Ribeiro A, Lindmarker P, Johnsson H et al (1999) Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 99:1325–1330. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/01.cir.99.10.1325" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/01.cir.99.10.1325</a></pub-id>
- Rodriguez AL, Wojcik BM, Wrobleski SK et al. (2012) Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis 33:371–382. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s11239-012-0687-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11239-012-0687-9</a></pub-id>
- Rosenkranz AC, Schror K, Rauch BH (2011) Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells. Thromb Haemost 106:561–562. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1160/TH11-04-0275" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1160/TH11-04-0275</a></pub-id>
- Sakr Y, M. Giovini M, Leone M et al (2020) Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care 10:124. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1186/s13613-020-00741-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s13613-020-00741-0</a></pub-id>
- Schoepf UJ, Kucher N, Kipfmueller F et al (2004) Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 110:3276–3280. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/01.CIR.0000147612.59751.4C" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/01.CIR.0000147612.59751.4C</a></pub-id>
- Shabanzadeh AP, Shuaib A, Wang CX (2005) Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res 1042:1–5. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.brainres.2005.01.105" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.brainres.2005.01.105</a></pub-id>
- Sorensen HT, Horvath-Puho E, Pedersen L et al (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370:1773–1779. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/S0140-6736(07)61745-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0140-6736(07)61745-0</a></pub-id>
- Sorensen HT, Horvath-Puho E, Sogaard KK et al (2009) Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 7:521–528. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/j.1538-7836.2009.03279.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1538-7836.2009.03279.x</a></pub-id>
- Souza-Costa DC, T. Zerbini T, A. C. Palei AC et al (2005) L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest 128:3705–3710. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1378/chest.128.5.3705" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1378/chest.128.5.3705</a></pub-id>
- Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC et al (2007) Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Crit Care Med 35:239–245. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1097/01.CCM.0000251638.67104.C3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/01.CCM.0000251638.67104.C3</a></pub-id>
- Springall R, Gonzalez-Flores J, Garcia-Avila C et al (2022) Elevated levels of soluble CD147 are associated with hyperinflammation and disease severity in COVID-19: A proof-of-concept clinical study. Arch Immunol Ther Exp 70:18. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s00005-022-00657-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00005-022-00657-6</a></pub-id>
- Squizzato A, Galli M, Romualdi E et al (2010) Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J 31:1248–1256. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/eurheartj/ehp556" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/eurheartj/ehp556</a></pub-id>
- Sreejit G, Johnson J, Jaggers RM et al (2022) Neutrophils in cardiovascular disease: warmongers, peacemakers, or both? Cardiovasc Res 118:2596–2609. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab302" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab302</a></pub-id>
- Sun TW, Zhang JY, Li L et al (2011) Effect atorvastatin on serum tumor necrosis factor alpha and interleukin-1beta following acute pulmonary embolism. Exp Lung Res 37:78–81. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.3109/01902148.2010.514647" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3109/01902148.2010.514647</a></pub-id>
- Takahashi M (2022) NLRP3 inflammasome as a key driver of vascular disease. Cardiovasc Res 118:372–385. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab010" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab010</a></pub-id>
- Tang Z, Wang X, Huang J et al (2016) Gene expression profiling of pulmonary artery in a rabbit model of pulmonary thromboembolism. PLoS One 11:e0164530. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1371/journal.pone.0164530" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1371/journal.pone.0164530</a></pub-id>
- Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent C, Windecker S et al (2022) European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res 118:1385–1412. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/cvr/cvab342" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/cvr/cvab342</a></pub-id>
- Tsang J, Simon M, Stewart K et al (2002) Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs. J Invest Surg 15:29–35. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1080/08941930252807769" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1080/08941930252807769</a></pub-id>
- Veras FP, Gomes GF, Silva BMS et al (2023) Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respir Res 24:66. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1186/s12931-023-02336-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s12931-023-02336-2</a></pub-id>
- Wakefield TW, Strieter RM, Wilke CA et al (1995) Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 15:258–268. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1161/01.atv.15.2.258" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1161/01.atv.15.2.258</a></pub-id>
- Wakefield TW, Strieter RM, Downing LJ et al (1996) P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 64:26–31. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1006/jsre.1996.0301" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1006/jsre.1996.0301</a></pub-id>
- Walcheck B, Moore KL, McEver RP et al (1996) Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 98:1081–1087. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1172/JCI118888" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1172/JCI118888</a></pub-id>
- Wang Y, Yu D, Yu Y et al (2020) Association Between inflammatory mediators and pulmonary blood flow in a rabbit model of acute pulmonary embolism combined with shock. Front Physiol 11:1051. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.3389/fphys.2020.01051" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3389/fphys.2020.01051</a></pub-id>
- Watts JA, Zagorski J, Gellar MA et al (2006) Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol 41:296–307. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.yjmcc.2006.05.011" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.yjmcc.2006.05.011</a></pub-id>
- Watts JA, Gellar MA, Obraztsova M et al (2008) Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats. Int J Exp Pathol 89:389–399. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2613.2008.00610.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2613.2008.00610.x</a></pub-id>
- Wood KE (2002) Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1378/chest.121.3.877" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1378/chest.121.3.877</a></pub-id>
- Zagorski J, Debelak J, Gellar M et al (2003) Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. J Immunol 171:5529–5536. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.4049/jimmunol.171.10.5529" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.4049/jimmunol.171.10.5529</a></pub-id>
- Zagorski J, Gellar MA, Obraztsova M et al (2007) Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J Immunol 179:7820–7826. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.4049/jimmunol.179.11.7820" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.4049/jimmunol.179.11.7820</a></pub-id>
- Zagorski J, Sanapareddy N, Gellar MA et al (2008) Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats. Physiol Genomics 34:101–111. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1152/physiolgenomics.00261.2007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1152/physiolgenomics.00261.2007</a></pub-id>
- Zagorski J, Obraztsova M, Gellar MA et al (2009) Transcriptional changes in right ventricular tissues are enriched in the out-flow tract compared with the apex during chronic pulmonary embolism in rats. Physiol Genomics 39:61–71. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1152/physiolgenomics.00076.2009" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1152/physiolgenomics.00076.2009</a></pub-id>
- Zagorski J, Kline JA (2016) Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome. Respir Res 17:86. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1186/s12931-016-0405-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s12931-016-0405-9</a></pub-id>
- Zhao YD, Yun HZH, Peng J et al (2014) De novo synthesize of bile acids in pulmonary arterial hypertension lung. Metabolomics 10:1169–1175. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s11306-014-0653-y" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11306-014-0653-y</a></pub-id>
- Zhou Q, Bea F, Preusch M et al (2011) Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban. Mediators Inflamm 2011:432080. doi: <pub-id pub-id-type="doi"><a href="https://doi.org/10.1155/2011/432080" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2011/432080</a></pub-id>
DOI: https://doi.org/10.2478/aite-2024-0003 | Journal eISSN: 1661-4917
Language: English
Submitted on: Aug 24, 2023
Accepted on: Dec 5, 2023
Published on: Jan 24, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2024 Anna M. Imiela, Tomasz P. Mikołajczyk, Tomasz J. Guzik, Piotr Pruszczyk, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.